Literature DB >> 20064132

Complications affecting preterm neonates from 1991 to 2006: what have we gained?

F Groenendaal1, J U M Termote, M van der Heide-Jalving, I C van Haastert, L S de Vries.   

Abstract

AIM: In this study, we determined whether outcome of preterm neonates has improved over a period of 16 years. STUDY
DESIGN: Inborn neonates with a gestational age of 25.0-29.9 weeks were included. Patients with severe congenital malformations were excluded. Mortality and morbidity (chronic lung disease; CLD, intraventricular haemorrhage: IVH grade III or IV, cystic periventricular leukomalacia: cPVL, perforated necrotizing enterocolitis: NEC, severe retinopathy of prematurity needing surgery: ROP and cerebral palsy: CP) were compared in three periods (period 1: 1991-1996 n = 434; period 2: 1997-2001 n = 356; period 3: 2002-2006 n = 422).
RESULTS: Infant mortality decreased from 15.2% to 10.9%. CLD did not differ significantly between periods (14.1-14.8%). Perforated NEC decreased from 2.8% to 1.6%. IVH grade III and IV both remained at 5.7% in period 3, whereas cPVL decreased significantly from 4.5% to 1.6%. Cerebral palsy decreased from 5.8% to 3.5% in period 3. Two neonates in each period were in need of surgery for ROP.
CONCLUSION: Inborn preterm patients showed an improved survival and a significant reduction in cPVL and CP. Perforated NEC showed a trend to decrease. CLD and IVH grade III and IV remain a matter of concern.

Entities:  

Mesh:

Year:  2010        PMID: 20064132     DOI: 10.1111/j.1651-2227.2009.01648.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  20 in total

Review 1.  Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.

Authors:  Kate O'Hara; Ian M R Wright; Jennifer J Schneider; Alison L Jones; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

2.  Brain injury in premature neonates: A primary cerebral dysmaturation disorder?

Authors:  Stephen A Back; Steven P Miller
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

Review 3.  White matter injury in the preterm infant: pathology and mechanisms.

Authors:  Stephen A Back
Journal:  Acta Neuropathol       Date:  2017-05-22       Impact factor: 17.088

4.  Fine particulate matter and risk of preterm birth and pre-labor rupture of membranes in Perth, Western Australia 1997-2007: a longitudinal study.

Authors:  Gavin Pereira; Michelle L Bell; Kathleen Belanger; Nicholas de Klerk
Journal:  Environ Int       Date:  2014-08-10       Impact factor: 9.621

Review 5.  Imaging the premature brain: ultrasound or MRI?

Authors:  Linda S de Vries; Manon J N L Benders; Floris Groenendaal
Journal:  Neuroradiology       Date:  2013-07-10       Impact factor: 2.804

Review 6.  Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management.

Authors:  Stephen A Back
Journal:  Clin Perinatol       Date:  2014-03       Impact factor: 3.430

7.  Association of cord blood digitalis-like factor and necrotizing enterocolitis.

Authors:  Steven W Graves; Michael S Esplin; Paula McGee; Dwight J Rouse; Kenneth J Leveno; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Donald J Dudley; Steven N Caritis
Journal:  Am J Obstet Gynecol       Date:  2013-11-08       Impact factor: 8.661

Review 8.  Brain Injury in the Preterm Infant: New Horizons for Pathogenesis and Prevention.

Authors:  Stephen A Back
Journal:  Pediatr Neurol       Date:  2015-04-18       Impact factor: 3.372

Review 9.  Cerebral artery signal transduction mechanisms: developmental changes in dynamics and Ca2+ sensitivity.

Authors:  Lawrence D Longo; Ravi Goyal
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

Review 10.  Cognitive Outcomes of Children Born Extremely or Very Preterm Since the 1990s and Associated Risk Factors: A Meta-analysis and Meta-regression.

Authors:  E Sabrina Twilhaar; Rebecca M Wade; Jorrit F de Kieviet; Johannes B van Goudoever; Ruurd M van Elburg; Jaap Oosterlaan
Journal:  JAMA Pediatr       Date:  2018-04-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.